Fig. 1From: Could potentially calprotectin be a promising biomarker to oracle biologic therapy response in rheumatoid arthritis?Box and Whisker plot of baseline serum calprotectin concentrations among the study cohort. Rheumatoid arthritis patients showed remarkably higher levels [404.1 (60.0–908.2 ng/ml)] as compared to the healthy controls [101.45 (0.0–183.7 ng/ml)]; P < 0.001Back to article page